BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32381123)

  • 1. Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF.
    Song YJ; Choi IA; Meylan F; Demoruelle MK; Farley T; Richard AC; Hawley E; Botson J; Hong YJ; Lee EY; Mian SR; Hamilton BC; Thiele GM; Mikuls TR; Gara N; Ward CD; Lamberth S; Deane KD; Heller T; Ward MM; Lee DM; Migone TS; Stohl W; O'Dell JR; Norris JM; Holers VM; Gregersen P; Song YW; Siegel RM
    Arthritis Res Ther; 2020 May; 22(1):106. PubMed ID: 32381123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
    Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
    Xiu Z; Shen H; Tian Y; Xia L; Lu J
    Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses.
    Wang X; Hu Y; Charpentier T; Lamarre A; Qi S; Wu J; Luo H
    J Immunol; 2013 Dec; 191(11):5420-9. PubMed ID: 24140642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.
    Bamias G; Siakavellas SI; Stamatelopoulos KS; Chryssochoou E; Papamichael C; Sfikakis PP
    Clin Immunol; 2008 Nov; 129(2):249-55. PubMed ID: 18757243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TL1A increased IL-6 production on fibroblast-like synoviocytes by preferentially activating TNF receptor 2 in rheumatoid arthritis.
    Ma Z; Wang B; Wang M; Sun X; Tang Y; Li M; Li F; Li X
    Cytokine; 2016 Jul; 83():92-98. PubMed ID: 27081759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis.
    Cassatella MA; Pereira-da-Silva G; Tinazzi I; Facchetti F; Scapini P; Calzetti F; Tamassia N; Wei P; Nardelli B; Roschke V; Vecchi A; Mantovani A; Bambara LM; Edwards SW; Carletto A
    J Immunol; 2007 Jun; 178(11):7325-33. PubMed ID: 17513783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TL1A in the pathogenesis of rheumatoid arthritis.
    Zhang J; Wang X; Fahmi H; Wojcik S; Fikes J; Yu Y; Wu J; Luo H
    J Immunol; 2009 Oct; 183(8):5350-7. PubMed ID: 19786547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Tumor Necrosis Like factor 1 A (TL1A) and its Decoy Receptor (DcR3) with The Disease Activity and Autoantibody Production in Rheumatoid Arthritis Patients.
    Soliman MH; Ebaid AM
    Egypt J Immunol; 2019 Jan; 26(1):43-54. PubMed ID: 31332995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.
    Bull MJ; Williams AS; Mecklenburgh Z; Calder CJ; Twohig JP; Elford C; Evans BA; Rowley TF; Slebioda TJ; Taraban VY; Al-Shamkhani A; Wang EC
    J Exp Med; 2008 Oct; 205(11):2457-64. PubMed ID: 18824582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis.
    Zhou M; Liu R; Su D; Feng X; Li X
    Cytokine; 2014 Sep; 69(1):125-30. PubMed ID: 24832108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TL1A/TNFR2-mediated mitochondrial dysfunction of fibroblast-like synoviocytes increases inflammatory response in patients with rheumatoid arthritis via reactive oxygen species generation.
    Al-Azab M; Qaed E; Ouyang X; Elkhider A; Walana W; Li H; Li W; Tang Y; Adlat S; Wei J; Wang B; Li X
    FEBS J; 2020 Jul; 287(14):3088-3104. PubMed ID: 31953914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; HeinegÄrd D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene polymorphisms and serum levels of TL1A in patients with rheumatoid arthritis.
    Yuan ZC; Wang JM; Su LC; Xu WD; Huang AF
    J Cell Physiol; 2019 Jul; 234(7):11760-11767. PubMed ID: 30488533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.
    Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS
    Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TL1A mediates fibroblast-like synoviocytes migration and Indian Hedgehog signaling pathway via TNFR2 in patients with rheumatoid arthritis.
    Al-Azab M; Wei J; Ouyang X; Elkhider A; Walana W; Sun X; Tang Y; Wang B; Li X
    Eur Cytokine Netw; 2018 Mar; 29(1):27-35. PubMed ID: 29748156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis.
    Bamias G; Stamatelopoulos K; Zampeli E; Protogerou A; Sigala F; Papamichael C; Christopoulos P; Kitas GD; Sfikakis PP
    Clin Immunol; 2013 May; 147(2):144-50. PubMed ID: 23598291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis: comments on the article by Sun et al.
    Cao L; Xu T; Huang C; Li J
    Scand J Rheumatol; 2014; 43(2):175. PubMed ID: 24559200
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
    Aiba Y; Nakamura M
    Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate chronotherapy is effective against rheumatoid arthritis.
    To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K
    Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.